MedPath
NMPA Approval

Peramivir Injection

国药准字H20244152

June 25, 2024

Drug Information

帕拉米韦注射液

注射剂

15ml∶0.15g(按 C₁₅H₂₈N₄O₄计)

化学药品

June 25, 2024

Company Information

Applicant Company

湖北省黄石市下陆区大泉路120号

Manufacturing Company

湖北省黄石市下陆区大泉路120号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath